University of California San Francisco
Give to UCSFFor the first time, an immunosuppressive agent has shown better organ survival in kidney transplant recipients than a calcineurin inhibitor, the current standard of care, according to a worldwide study led by UC San Francisco and Emory University investigators.
Development of a surgically implantable, artificial kidney has received a $6 million boost, thanks to a new grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB).
Heart and lung transplant recipients are living longer than ever before, thanks to rapid advances in technology, medications and surgical procedures. That progress was cause for celebration last month at UCSF, where 400 patients and families gathered.
Voriconazole, a prescription drug commonly used to treat fungal infections in lung transplant recipients, significantly increases the risk for skin cancer and even death, according to a new study by UCSF researchers.
A UCSF study has found when self-identification matters most – in connecting bone marrow donors to patients – the format of the questions may determine how well the answers correspond to their genes.
Mild hypothermia in deceased organ donors significantly reduces delayed graft function in kidney transplant recipients when compared to normal body temperature, according to UCSF researchers and collaborators.
A unique collaboration resulted in one of the nation’s first nine-way kidney transplant chains occurring in one city over a 36-hour period.
A previously unknown type of cell regenerates mouse lung tissue killed by the flu virus, according to a new study led by UCSF scientists.
Researchers at UCSF have developed a potential test for diagnosing and predicting acute rejection in kidney transplants.